Coya Therapeutics completes phase 2 study of LD IL-2 in patients with Alzheimer’s disease: Houston Friday, May 24, 2024, 18:00 Hrs [IST] Coya Therapeutics, Inc, a clinical-stage ...

Deepak Sapra, CEO, Dr Reddy’s Labs: Our Bureau, Mumbai Friday, May 24, 2024, 17:40 Hrs [IST] The technology enables d ...

South San Francisco, California Friday, May 24, 2024, 17:00 Hrs [IST] ...

Sun Pharmaceutical Industries Limited and Taro Pharmaceutical Industries Ltd. announced that the merger agreement between Taro and Sun Pharma was approved by the affirmative vote of Taro shareholders ...

Bharat Biotech chief Dr Krishna Ella gets Johns Hopkins Bloomberg School Highest Medal of Honour for work in public health: Our Bureau, Bengaluru Friday, May 24, 2024, 16:40 Hrs [ ...

Oxford Nanopore collaborates with Twist Bioscience to launch PGx Beta Programme and advance personalised medicine: United Kingdom Friday, May 24, 2024, 16:00 Hrs [IST] Oxford Nano ...

Cambridge Biotherapies, a leading mental health treatment provider in Massachusetts, announced the launch of Ketamine Infusions for pain and headache management, now available at all locations. This ...

Intuitive’s largest multi-institutional study on partial nephrectomy supports the efficacy of robotic-assisted renal mass surgery: Our Bureau, Bengaluru Friday, May 24, 2024, 15 ...

Geneva, Switzerland Friday, May 24, 2024, 15:00 Hrs [IST] ...

Healthcare delivery major Fortis Healthcare has registered a 47 per cent growth in net profit at Rs. 203.14 crore during the fourth quarter of the fiscal year ended March 31, 2024, as compared to Rs.

Biocon inks exclusive licensing and supply deal with Handok for commercialization of Liraglutide in South Korea: Our Bureau, Bengaluru Friday, May 24, 2024, 14:30 Hrs [IST] Biocon ...

Novartis Pharma Co., Ltd. and Otsuka Pharmaceutical Co., Ltd. announced the launch of angiotensin receptor neprilysin inhibitor (ARNI) “Enrest Granular tablets for paediatrics 12.5 mg and 31.25 mg'', ...